01 / Research notes
Focus and cognition need a diagnosis
Concentration problems can reflect poor sleep, depression, anxiety, medication effects, attention disorders, or medical illness. A peptide search should not replace that evaluation. Published human exposure does not establish benefit for every promoted cognitive use.
02 / Research notes
What the policy says
For Semax, HHS identifies the free-base form and intranasal route in its interim policy. The policy's single-ingredient, sourcing, testing, labeling, reporting, and patient-specific prescription conditions still apply. A Semax/Selank combination is not covered by the single-ingredient condition.
03 / Research notes
Safety and alternatives
Human safety evidence is limited for US compounded formulations, and quality concerns matter. Bring your symptoms, medicines, sleep history, and goals to a clinician who can discuss established approaches and whether further evaluation is needed.
Evidence and safety in context
Semax has been studied for neurological effects, but that does not establish that a US compounded product improves focus, memory, or mood. Cognitive symptoms can be related to sleep, mental health, medicines, or medical conditions that warrant evaluation.
FDA has raised possible immunogenicity related to aggregation and peptide impurities for compounded Semax. Research on a different formulation or use cannot settle the safety or benefit of the exact intranasal product being considered.
Questions for a clinical visit
- What could explain the focus or memory change?
- Which established treatments or further tests are appropriate?
- Does the proposed formulation match the free-base intranasal scope of the HHS policy?
See how the HHS policy works and how to prepare for a consultation.
Common questions about Semax
Is Semax FDA approved in the United States?
No. The HHS interim policy does not grant FDA approval.
Can Semax and Selank be combined?
A combined Semax/Selank product is outside the interim policy's single listed active ingredient condition.
Does Semax improve memory or focus?
The evidence does not establish a reliable benefit for a US compounded Semax product.
Are Semax injections covered by this HHS policy?
The interim policy specifies Semax free base by the intranasal route, not an injectable product.
Important information
HHS's interim policy is conditional and may be revisited. Compounded products are not FDA approved and have not undergone FDA review for safety, effectiveness, or quality before marketing. Treatment through Jonathan Larson MDPC requires a clinical evaluation; a licensed provider decides whether any prescription is medically necessary and appropriate. This guide is informational and is not medical advice.
Read the HHS policy ↗